Tuesday, February 20, 2018 10:15 PM ET
Zimmer Biomet Holdings (ZBH) sees Significant Insider buy Reversing Trend of Selling over Last Quarter
There was a noteworthy insider buying activity in Zimmer Biomet Holdings shares today as revealed in a filing with the SEC. One insider — Bryan C Hanson, Director and Officer — purchased 25,077 shares in the company having a net market value of approximately $3,001,210. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 6,282 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 18,795 shares and have averaged 15,680 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at Zimmer Biomet Holdings is greater than its 83-company peer group average. The Medical Equipment, Supplies & Distribution peer group saw 89 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by Zimmer Biomet Holdings insiders is lower than its peers. Within the peer group there were 4,230,939 shares purchased and 8,472,397 shares sold with company insiders disposing of 47,657 shares on average over this time period.
The data sourced in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2018 UpTick Data Technologies. All rights reserved.